July 24, 2016 1:00 PM ET

Biotechnology

Company Overview of Biosceptre International Limited

Company Overview

Biosceptre International Limited, a biotechnology company, develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. It develops a range of polyclonal, monoclonal, and domain antibodies for use in IVDs, topical therapeutics, in vivo imaging diagnostics, systemic therapeutics, and vaccines. The company was founded in 2000 and is based in North Ryde, Australia.

Suite 3.08

56 Delhi Road

North Ryde, NSW 2113

Australia

Founded in 2000

Phone:

61 2 9889 1202

Fax:

61 2 9887 4777

Key Executives for Biosceptre International Limited

Chief Executive Officer and Executive Director
Director of Investor Relations
Compensation as of Fiscal Year 2016.

Biosceptre International Limited Key Developments

Gregory Winter Joins Biosceptre as Non-Executive Director

Biosceptre announced that Sir Gregory Winter has taken a board position as non-executive Director. Sir Gregory has been strongly associated with Biosceptre since 2011 as chair of its Scientific Advisory Board. In this role, he provided invaluable guidance driving a better understanding of Biosceptre's novel nfP2X7 oncology target and translation of the science to enable development of three promising therapeutic candidates. Based on this significant progress to date, Sir Gregory will now take on a broader role within Biosceptre.

Biosceptre International Limited Presents at Sachs Associates 2nd Annual Immune-Oncology BD&L and Investment Forum, Jun-03-2016 11:00 AM

Biosceptre International Limited Presents at Sachs Associates 2nd Annual Immune-Oncology BD&L and Investment Forum, Jun-03-2016 11:00 AM. Venue: Hyatt Chicago Magnificent Mile, 633 North Saint Clair Street, Chicago, IL 60611, United States. Speakers: Shaun McNulty, Chief Scientific Officer.

Biosceptre International Limited Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-11-2016 through Jan-13-2016

Biosceptre International Limited Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-11-2016 through Jan-13-2016. Venue: Parc 55 San Francisco, 55 Cyril Magnin Street, San Francisco, CA 94102, United States. Presentation Date(s): Jan-11-2016.

Similar Private Companies By Industry

Company Name Region
AbRegen Pty Ltd. Asia
Adalta Limited Asia
Advanced Wound Care Pty Ltd. Asia
Agriliance Pty Ltd. Asia
AION Diagnostics Limited Asia

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Biosceptre International Limited, please visit www.biosceptre.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.